DCF — UC DAVIS MEDICAL CENTER
Enterprise Value: $-5.9B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-5.9B
Enterprise Value
$-1.8B
PV of Cash Flows
$-4.0B
PV of Terminal Value
$-6.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $3.4B | $-371.1M | -11.0% | $-514.0M | $-467.3M |
| Year 2 | $3.5B | $-347.5M | -10.0% | $-494.6M | $-408.8M |
| Year 3 | $3.6B | $-322.1M | -9.0% | $-473.7M | $-355.9M |
| Year 4 | $3.7B | $-313.3M | -8.0% | $-469.4M | $-320.6M |
| Year 5 | $3.8B | $-313.2M | -8.0% | $-474.0M | $-294.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-5.9B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$3.3B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11492905489800467
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5